UBS Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.22M | Buy |
320,545
+4,886
| +2% | +$141K | ﹤0.01% | 2482 |
|
|
2025
Q1 | $10.6M | Sell |
315,659
-392,071
| -55% | -$13.2M | ﹤0.01% | 2308 |
|
|
2024
Q4 | $36.2M | Buy |
707,730
+524,844
| +287% | +$26.8M | 0.01% | 1331 |
|
|
2024
Q3 | $9.35M | Sell |
182,886
-56
| -0% | -$2.86K | ﹤0.01% | 1729 |
|
|
2024
Q2 | $8.19M | Sell |
182,942
-64,861
| -26% | -$2.91M | ﹤0.01% | 1751 |
|
|
2024
Q1 | $11.6M | Buy |
247,803
+109,338
| +79% | +$5.12M | ﹤0.01% | 1520 |
|
|
2023
Q4 | $4.93M | Buy |
138,465
+56,607
| +69% | +$2.01M | ﹤0.01% | 2019 |
|
|
2023
Q3 | $2.43M | Sell |
81,858
-63,835
| -44% | -$1.9M | ﹤0.01% | 2404 |
|
|
2023
Q2 | $2.63M | Buy |
145,693
+86,525
| +146% | +$1.56M | ﹤0.01% | 2464 |
|
|
2023
Q1 | $950K | Sell |
59,168
-21,526
| -27% | -$346K | ﹤0.01% | 3218 |
|
|
2022
Q4 | $1.48M | Buy |
80,694
+72,555
| +891% | +$1.33M | ﹤0.01% | 2813 |
|
|
2022
Q3 | $160K | Sell |
8,139
-11,041
| -58% | -$217K | ﹤0.01% | 4252 |
|
|
2022
Q2 | $358K | Sell |
19,180
-49,313
| -72% | -$920K | ﹤0.01% | 3573 |
|
|
2022
Q1 | $1.5M | Buy |
68,493
+15,673
| +30% | +$344K | ﹤0.01% | 2895 |
|
|
2021
Q4 | $1.5M | Buy |
52,820
+31,593
| +149% | +$897K | ﹤0.01% | 3119 |
|
|
2021
Q3 | $447K | Buy |
+21,227
| New | +$447K | ﹤0.01% | 3803 |
|
|
2021
Q2 | – | Sell |
-4,129
| Closed | -$63K | – | 8294 |
|
|
2021
Q1 | $63K | Buy |
4,129
+2,030
| +97% | +$31K | ﹤0.01% | 5327 |
|
|
2020
Q4 | $30K | Buy |
+2,099
| New | +$30K | ﹤0.01% | 5624 |
|
|
2020
Q3 | – | Sell |
-9,093
| Closed | -$159K | – | 7121 |
|
|
2020
Q2 | $159K | Buy |
9,093
+877
| +11% | +$15.3K | ﹤0.01% | 4158 |
|
|
2020
Q1 | $121K | Sell |
8,216
-8,871
| -52% | -$131K | ﹤0.01% | 4265 |
|
|
2019
Q4 | $429K | Buy |
17,087
+7,888
| +86% | +$198K | ﹤0.01% | 4015 |
|
|
2019
Q3 | $138K | Buy |
9,199
+8,514
| +1,243% | +$128K | ﹤0.01% | 4637 |
|
|
2019
Q2 | $17K | Sell |
685
-42,731
| -98% | -$1.06M | ﹤0.01% | 5850 |
|
|
2019
Q1 | $988K | Buy |
43,416
+42,821
| +7,197% | +$974K | ﹤0.01% | 2950 |
|
|
2018
Q4 | $18K | Sell |
595
-1,042
| -64% | -$31.5K | ﹤0.01% | 5944 |
|
|
2018
Q3 | $47K | Buy |
+1,637
| New | +$47K | ﹤0.01% | 5309 |
|